AI assistant
ARIX BIOSCIENCE PLC Report Publication Announcement 2019
4968_rns_2019-08-20_66988fc6-d8d0-4348-b493-59fc3d4d2f8e.html
Report Publication Announcement
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
Arix Bioscience Plc - Notice of Results
PR Newswire
London, August 20
Arix Bioscience plc
Notice of Results
LONDON, 20 August 2019: Arix Bioscience plc (“Arix”, LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, will announce its interim results for the six months ended 30 June 2019, on Wednesday, 28 August 2019.
A presentation and webcast for analysts will be held on the day of results at 12:30pm BST at the Devonshire Club, 5 Devonshire Square, London, EC2M 4YD. Details of the webcast will be available on request. The webcast will be recorded, and a replay will be available on the Company's website at https://arixbioscience.com/investor-relations/results-centre
ENDS
Enquiries
For more information on Arix, please contact:
Arix Bioscience plc
Charlotte Parry, Head of Investor Relations
+44 (0)20 7290 1072
Optimum Strategic Communications
Mary Clark, Supriya Mathur
T: +44 (0) 203 950 9144
About Arix Bioscience plc
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
For further information, please visit www.arixbioscience.com
